Temporal patterns of electrical remodeling in canine ventricular hypertrophy: focus on IKs downregulation and blunted beta-adrenergic activation

Cardiovasc Res. 2006 Oct 1;72(1):90-100. doi: 10.1016/j.cardiores.2006.07.015. Epub 2006 Jul 25.

Abstract

Objectives: Electrical remodeling in cardiac hypertrophy often involves the downregulation of K+ currents, including beta-adrenergic (beta-A)-sensitive IKs. Temporal patterns of ion-channel downregulation are poorly resolved. In dogs with complete atrioventricular block (AVB), we examined (1) the time course of molecular alterations underlying IKs downregulation from acute to chronic hypertrophy; and (2) concomitant changing responses of repolarization to beta-adrenergic receptor (beta-AR) stimulation.

Methods and results: Serial left-ventricular (LV) biopsies were collected from anesthetized dogs during sinus rhythm (SR; control) and at 3, 7 and 30 days of AVB. KCNQ1 mRNA and protein decreased within 3 days (protein expression 58 +/- 10% of control), remaining low thereafter. beta1-AR mRNA and protein decreased more gradually to 53 +/- 8% at 7 days. In chronic-AVB LV myocytes, IKs -tail density was reduced: 1.4 +/- 0.3 pA/pF versus 2.6 +/- 0.4 pA/pF in controls. beta-A enhancement of IKs was reduced. Isoproterenol shortened action-potential duration in control cells, while causing heterogeneous repolarization responses in chronic AVB. beta-A early afterdepolarizations were induced in 4 of 13 chronic-AVB cells, but not in controls. In intact conscious dogs, isoproterenol shortened QTc at SR (by -8 +/- 3% from 295 ms), left it unaltered at 3 days AVB (+1 +/- 3% from 325 ms) and prolonged QTc at 30 days (+6 +/- 3% from 365 ms).

Conclusions: Profound decrease of KCNQ1 occurs within days after AVB induction and is followed by a more gradual decrease of beta1-AR expression. Downregulation and blunted beta-A activation of IKs contribute to the loss of beta-A-induced shortening of ventricular repolarization, favoring proarrhythmia. Provocation testing with isoproterenol identifies repolarization instability based on acquired channelopathy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Adrenergic beta-Antagonists / pharmacology
  • Animals
  • Blotting, Western
  • Chromans / pharmacology
  • Dogs
  • Down-Regulation*
  • Electrocardiography
  • Epinephrine / metabolism
  • Female
  • Heart Block
  • Hypertrophy, Left Ventricular / metabolism
  • Hypertrophy, Left Ventricular / physiopathology*
  • Isoproterenol / pharmacology
  • KCNQ1 Potassium Channel / metabolism
  • Male
  • Membrane Potentials / drug effects
  • Myocardium / metabolism*
  • Patch-Clamp Techniques
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels, Voltage-Gated / metabolism*
  • RNA, Messenger / analysis
  • Receptors, Adrenergic, beta-1 / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sulfonamides / pharmacology
  • Time Factors

Substances

  • Adrenergic beta-Antagonists
  • Chromans
  • HMR 1556
  • KCNQ1 Potassium Channel
  • Potassium Channel Blockers
  • Potassium Channels, Voltage-Gated
  • RNA, Messenger
  • Receptors, Adrenergic, beta-1
  • Sulfonamides
  • Isoproterenol
  • Epinephrine